Will A. Sherman

Will A. Sherman

Auto-generated profile, based on publicly available information

Will A. Sherman

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2025 in Clinical Cancer Research
Verified
Journal Article
Closed access
BSBahar Saberzadeh-Ardestani
Bahar Saberzadeh-Ardestani
ZLZhenglong Liu
Zhenglong Liu
MSMariam I. Stein
Mariam I. Stein
WSWill A. Sherman
Will A. Sherman
CTChristy E. Trussoni
Christy E. Trussoni
FSFrank Sinicrope
Frank Sinicrope
Purpose: Digital proteomic profiling was performed to identify spatial context in relationship to patient response and survival after anti–PD-1 therapy in metastatic colorectal cancer. Experimental Design: Primary colorectal cancers with deficient mismatch repair from patients treated with anti–PD-1 antibodies were analyzed (N = 30) using digital spatial profiling (GeoMx nCounter). At the invasive margin, 71 proteins were profiled in 10 regions of interest/slide that were segmented into 3 compartments labeled with pan-cytokeratin (epithelia), CD45 (stromal cells), and SYTO13 (nuclei). In an independent cohort (n = 13), digital spatial profiling data and single-cell transcriptomic data were analyzed. Differential protein abundance, after Benjamini–Hochberg correction, was examined by clinical response and progression-free survival (PFS) using multivariable Cox regression. Results: Protein abundance varied significantly between epithelial and stromal compartments. Nonresponders to anti–PD-1 showed higher fibronectin and smooth muscle actin abundance in the epithelial compartment that was associated with significantly shorter PFS (adjusted HR: 6.49 and 4.52, respectively; P < 0.05). In CD45+ stroma, increased expression of proteins related to T cells (CD3 and CD4), NK cells (CD56), antigen presentation (CD40), immune activation (CD27, ICOS), and apoptosis (GZMA) were found in responders (vs nonresponders) to anti–PD-1; each marker was significantly associated with longer patient PFS (0.02 < adjusted HR < 0.17; P < 0.05). In a separate cohort, consistent results by compartment were found for fibronectin and CD56. Gene expression data revealed that fibronectin and smooth muscle actin were primarily derived from cancer-associated fibroblasts. Conclusions: Spatially resolved protein profiles within microenvironments of deficient mismatch repair colorectal cancers can influence patient response and survival after anti–PD-1, highlighting their potential clinical significance.

18 February 2025 in Clinical Cancer Research
Verified
Journal Article
Closed access
KBKathleen R. Bartemes
Kathleen R. Bartemes
RMRaymond Moore
Raymond Moore
BNBrenna C. Novotny
Brenna C. Novotny
KPKevin Daniel Pavelko
Kevin Daniel Pavelko
WSWill A. Sherman
Will A. Sherman
DRDavid M. Routman
David M. Routman
Purpose: Tumor-infiltrating lymphocytes are associated with a decreased risk of recurrence in human papillomavirus–associated oropharyngeal squamous cell carcinoma. The composition and spatial distribution of tumor-infiltrating lymphocytes and tumor-infiltrating immune cells are not well characterized. Experimental Design: Formalin-fixed, paraffin-embedded primary and lymph node (LN) tumor tissues from 10 progressors (cases) and 10 matched nonprogressors (controls) were interrogated by imaging mass cytometry. Immune, stromal, and tumor cells were quantified from selected regions of interest using machine learning. Nearest neighbors, cell–cell interactions, and niche analyses were performed. Results: In primary regions of interest, immune cell, lymphocyte, T cell, CD8+ T cell, and innate cell prevalence was significantly greater in controls. High prevalence of immune cells, lymphocytes, innate cells, and CD4+ T cells in primary tissues was significantly associated with increased time to event (TTE). Although primary and LN prevalence of T cells, CD4+ T cells, CD8+ T cells, macrophages, and tumor cells were significantly correlated, differences in LNs were neither significant nor associated with TTE. Average distances between T cells and the nearest B cells and between lymphocytes and the nearest tumor cells were decreased in control primary tissues. Interactions between B and T cells were less organized in primary tissues from cases. A niche predominantly comprising lymphocytes was associated with longer TTE. Conclusions: In human papillomavirus–associated oropharyngeal squamous cell carcinoma, immune cell subset prevalence in primary tumors differs with outcome and is associated with TTE. Interactions between B cells and both T-cell subsets are associated with longer TTE, underscoring the importance of active intratumoral immune responses in outcomes.

17 June 2026
Verified
Other
Open access
KBKathleen R. Bartemes
Kathleen R. Bartemes
RMRaymond Moore
Raymond Moore
BNBrenna C. Novotny
Brenna C. Novotny
KPKevin Daniel Pavelko
Kevin Daniel Pavelko
WSWill A. Sherman
Will A. Sherman
DRDavid M. Routman
David M. Routman
High and low cut-offs for cell prevalence Kaplan-Meier plots

17 June 2026
Verified
Other
Open access
KBKathleen R. Bartemes
Kathleen R. Bartemes
RMRaymond Moore
Raymond Moore
BNBrenna C. Novotny
Brenna C. Novotny
KPKevin Daniel Pavelko
Kevin Daniel Pavelko
WSWill A. Sherman
Will A. Sherman
DRDavid M. Routman
David M. Routman
Kaplan-Meier plots of LN tumor tissues, comparing time to event for high and low levels of immune and tumor cell populations

17 June 2026
Verified
Other
Open access
KBKathleen R. Bartemes
Kathleen R. Bartemes
RMRaymond Moore
Raymond Moore
BNBrenna C. Novotny
Brenna C. Novotny
KPKevin Daniel Pavelko
Kevin Daniel Pavelko
WSWill A. Sherman
Will A. Sherman
DRDavid M. Routman
David M. Routman
Kaplan-Meier plots of primary tumor tissues, comparing time to event for high and low average nearest neighbor distances between lymphocytes

17 June 2026
Verified
Other
Open access
KBKathleen R. Bartemes
Kathleen R. Bartemes
RMRaymond Moore
Raymond Moore
BNBrenna C. Novotny
Brenna C. Novotny
KPKevin Daniel Pavelko
Kevin Daniel Pavelko
WSWill A. Sherman
Will A. Sherman
DRDavid M. Routman
David M. Routman
Graphic depictions of stromal cell and immune cell populations that did not differ proportionally in ROIs among the clinical groups